These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31269854)

  • 1. Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361).
    Brooks SP; Benjaminy S; Bubela T
    Ophthalmic Genet; 2019 Jun; 40(3):276-281. PubMed ID: 31269854
    [No Abstract]   [Full Text] [Related]  

  • 2. A qualitative assessment of the experience of participating in a cancer-related clinical trial.
    Wootten AC; Abbott JM; Siddons HM; Rosenthal MA; Costello AJ
    Support Care Cancer; 2011 Jan; 19(1):49-55. PubMed ID: 19960208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials.
    Benjaminy S; Macdonald I; Bubela T
    Genet Med; 2014 May; 16(5):379-85. PubMed ID: 24071795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.
    Boutron I; Haneef R; Yavchitz A; Baron G; Novack J; Oransky I; Schwitzer G; Ravaud P
    BMC Med; 2019 Jun; 17(1):105. PubMed ID: 31159786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants' experiences.
    Cox K
    Psychooncology; 2000; 9(4):314-22. PubMed ID: 10960929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicating with participants during the conduct of multi-center clinical trials.
    Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
    Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconsent education about research processes improved African Americans' willingness to participate in clinical research.
    Dunlop AL; Leroy ZC; Logue KM; Glanz K; Dunlop BW
    J Clin Epidemiol; 2011 Aug; 64(8):872-7. PubMed ID: 21330104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informal professionalization of healthy participants in phase I clinical trials in Russia.
    Zvonareva O; Pimenov I; Kutishenko N; Mareev I; Martsevich S; Kulikov E
    Clin Trials; 2019 Dec; 16(6):563-570. PubMed ID: 31647322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed Consent: Research Staff's Perspectives and Practical Recommendations to Improve Research Staff-Participant Communication.
    Eeckhout D; Aelbrecht K; Van Der Straeten C
    J Empir Res Hum Res Ethics; 2023; 18(1-2):3-12. PubMed ID: 36562147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing Patient Recruitment and Retention in a Secondary Stroke Prevention Clinical Trial: Lessons Learned from the STAND FIRM Study.
    Thayabaranathan T; Cadilhac DA; Srikanth VK; Fitzgerald SM; Evans RG; Kim J; Gerraty RP; Phan TG; Bladin CF; Nelson MR; Frayne JH; Thrift AG
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1371-80. PubMed ID: 27009610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.
    Nurgat ZA; Craig W; Campbell NC; Bissett JD; Cassidy J; Nicolson MC
    Br J Cancer; 2005 Mar; 92(6):1001-5. PubMed ID: 15770219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participant views and experiences of participating in HIV research in sub-Saharan Africa: a qualitative systematic review.
    Nalubega S; Evans C
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):330-420. PubMed ID: 26455613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PERSPECTIVES: Stroke survivors' views on the design of an early-phase cell therapy trial for patients with chronic ischaemic stroke.
    Nagpal A; Hillier S; Milton AG; Hamilton-Bruce MA; Koblar SA
    Health Expect; 2019 Oct; 22(5):1069-1077. PubMed ID: 31332894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroideremia research: Report and perspectives on the second international scientific symposium for choroideremia.
    Chan SC; Bubela T; Dimopoulos IS; Freund PR; Varkouhi AK; MacDonald IM
    Ophthalmic Genet; 2016 Sep; 37(3):267-75. PubMed ID: 26855058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Therapies for Choroideremia.
    Cehajic Kapetanovic J; Barnard AR; MacLaren RE
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31548516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the quality of life of patients in phase I and II anti-cancer drug trials: interviews versus questionnaires.
    Cox K
    Soc Sci Med; 2003 Mar; 56(5):921-34. PubMed ID: 12593867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials.
    Manton KJ; Gauld CS; White KM; Griffin PM; Elliott SL
    BMJ Open; 2019 Jan; 9(1):e024224. PubMed ID: 30647042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience.
    Dimopoulos IS; Hoang SC; Radziwon A; Binczyk NM; Seabra MC; MacLaren RE; Somani R; Tennant MTS; MacDonald IM
    Am J Ophthalmol; 2018 Sep; 193():130-142. PubMed ID: 29940166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.